USPTO serial 99301406
TRANSFORMING ACCESS. ENHANCING LIVES.
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 28, 2026
- Examiner
- GIPSOV, MARYNA K
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TRANSFORMING ACCESS. ENHANCING LIVES.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
JEFFERSONVILLE, IN, US
Jeffersonville, IN, US
Jeffersonville, IN, US
Jeffersonville, IN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Larry L. Coats
Larry L. Coats Coats & Bennett, PLLC1400 Crescent GreenSuite 300Cary, NC 27518Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business management and administration of pharmacy reimbursement programs for others; Managing and administering the distribution of prescription pharmaceutical samples, namely, prescription pharmaceutical sample distribution to physicians and patients; Mail-order pharmacy services; Business management and administration of patient co-pay reimbursement programs on behalf of pharmaceutical manufacturers; Business management and administration of financial assistance programs that provide patients with access to affordable medicine, namely business management and administration of patient enrollment and reimbursement programs for the purchase of medication and facilitating access to medications; Business management and administration of patient support programs, namely, programs for patient access and reimbursement coordination, benefits verification and prior authorization support, financial assistance and copay support, therapy initiation and treatment access, patient education and clinical support, and programs for patient care management and care coordination services on behalf of pharmaceutical manufacturers; Business management and administration of patient engagement programs, namely, programs for patient onboarding and enrollment, medication adherence, ongoing patient communications, medication reimbursements, and pharmacy reimbursements on behalf of pharmaceutical manufacturers; Business management and administration of formulary, patient, and payer policy information for pharmaceutical, medical device, and diagnostic manufacturers; Business management and administration of educational engagements for health care providers, namely, business management and administration of efforts to educate healthcare providers on medications, disease status and standard of care; Management of the distribution of clinical trial medication and supplies, namely, coordinating distribution of such medication and supplies from pharmaceutical manufacturers to clinical trial sites; Providing business marketing information regarding tracking pharmaceutical promotional programs for pharmaceutical manufacturers and evaluating and determining their effectiveness; Business data management services in the field of pharmaceutical patient safety, namely, collecting, compiling, storing and reporting adverse event data for business and regulatory compliance purposes; Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturers, namely, promoting public awareness of diseases, pharmaceutical brands, and treatment affordable options; Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturers, namely, marketing services in the nature of promotion of third party disease treatment option services by pharmaceutical manufacturers and disease treatment options via social media; Business information services, namely, providing business information regarding tracking payer coverage policies and related documentation to life sciences clients in order to enhance their market access strategies and patient support programs; Life science business strategy consulting services for assisting clients with commercial assessments, corporate and portfolio strategy, new product planning and commercialization support, and pricing and market access insights; Business assistance services, namely, business management and information services regarding enrolling patients of pharmaceutical manufacturers into support programs that enable patients to view, track, and manage the support program wherein the patient support program provides pharmaceutical consumer product information, payer coverage status updates, and providing business information regarding access to enrollment and reimbursement programs for the purchase of medications; Providing business information and business news to the pharmaceutical and life sciences industries on recent developments as it impacts and relates to the pharmaceutical and life sciences industries within the copay or patient affordability space | ACTIVE | Jul 10, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by VALERIS, INC.
- Other trademarks owned by Phantom Purchaser, Inc.
- Other trademarks owned by Phantom Purchaser, Inc.
- Other trademarks owned by Phantom Purchaser, Inc.
- Other trademarks in Class 035
- Similar marks named TRANSFORMING ACCESS. ENHANCING LIVES.
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 5, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 28, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 28, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 9, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 3, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 13, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 13, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 13, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 13, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 12, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 10, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 29, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 24, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 24, 2025 | NWAP | NEW APPLICATION ENTERED | — |